134 related articles for article (PubMed ID: 29270923)
1. Expression and Significance of MMPs in Synovial Fluid, Serum and PBMC Culture Supernatant Stimulated by LPS in Osteoarthritis Patients With or Without Diabetes.
Luo S; Shi Q; Chen J; Wang H; Wu W; Zha Z
Exp Clin Endocrinol Diabetes; 2019 Apr; 127(4):195-202. PubMed ID: 29270923
[TBL] [Abstract][Full Text] [Related]
2. Resistin as a factor in osteoarthritis: synovial fluid resistin concentrations correlate positively with interleukin 6 and matrix metalloproteinases MMP-1 and MMP-3.
Koskinen A; Vuolteenaho K; Moilanen T; Moilanen E
Scand J Rheumatol; 2014; 43(3):249-53. PubMed ID: 24780007
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase protein expression profiles cannot distinguish between normal and early osteoarthritic synovial fluid.
Heard BJ; Martin L; Rattner JB; Frank CB; Hart DA; Krawetz R
BMC Musculoskelet Disord; 2012 Jul; 13():126. PubMed ID: 22824140
[TBL] [Abstract][Full Text] [Related]
4. The expression of proinflammatory cytokines and matrix metalloproteinases in the synovial membranes of patients with osteoarthritis compared with traumatic knee disorders.
Wassilew GI; Lehnigk U; Duda GN; Taylor WR; Matziolis G; Dynybil C
Arthroscopy; 2010 Aug; 26(8):1096-104. PubMed ID: 20678708
[TBL] [Abstract][Full Text] [Related]
5. The potential of multiple synovial-fluid protein-concentration analyses in the assessment of knee osteoarthritis.
Driban JB; Balasubramanian E; Amin M; Sitler MR; Ziskin MC; Barbe MF
J Sport Rehabil; 2010 Nov; 19(4):411-21. PubMed ID: 21116010
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis.
Yoshihara Y; Nakamura H; Obata K; Yamada H; Hayakawa T; Fujikawa K; Okada Y
Ann Rheum Dis; 2000 Jun; 59(6):455-61. PubMed ID: 10834863
[TBL] [Abstract][Full Text] [Related]
7. Soluble biglycan: a potential mediator of cartilage degradation in osteoarthritis.
Barreto G; Soininen A; Ylinen P; Sandelin J; Konttinen YT; Nordström DC; Eklund KK
Arthritis Res Ther; 2015 Dec; 17():379. PubMed ID: 26703441
[TBL] [Abstract][Full Text] [Related]
8. Activation of matrix metalloproteinases 2, 9, and 13 by activated protein C in human osteoarthritic cartilage chondrocytes.
Jackson MT; Moradi B; Smith MM; Jackson CJ; Little CB
Arthritis Rheumatol; 2014 Jun; 66(6):1525-36. PubMed ID: 24574263
[TBL] [Abstract][Full Text] [Related]
9. Brief Report: Induction of Matrix Metalloproteinase Expression by Synovial Wnt Signaling and Association With Disease Progression in Early Symptomatic Osteoarthritis.
van den Bosch MH; Blom AB; van de Loo FA; Koenders MI; Lafeber FP; van den Berg WB; van der Kraan PM; van Lent PL
Arthritis Rheumatol; 2017 Oct; 69(10):1978-1983. PubMed ID: 28678406
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor activating kinase 1 regulates extracellular matrix degrading enzymes and pain-related molecule expression following tumor necrosis factor-α stimulation of synovial cells: an in vitro study.
Uchida K; Takano S; Matsumoto T; Nagura N; Inoue G; Itakura M; Miyagi M; Aikawa J; Iwase D; Minatani A; Fujimaki H; Takaso M
BMC Musculoskelet Disord; 2017 Jul; 18(1):283. PubMed ID: 28668088
[TBL] [Abstract][Full Text] [Related]
11. MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis.
Tchetverikov I; Ronday HK; Van El B; Kiers GH; Verzijl N; TeKoppele JM; Huizinga TW; DeGroot J; Hanemaaijer R
Ann Rheum Dis; 2004 Jul; 63(7):881-3. PubMed ID: 15194590
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase activity and prostaglandin E2 are elevated in the synovial fluid of meniscus tear patients.
Liu B; Goode AP; Carter TE; Utturkar GM; Huebner JL; Taylor DC; Moorman CT; Garrett WE; Kraus VB; Guilak F; DeFrate LE; McNulty AL
Connect Tissue Res; 2017; 58(3-4):305-316. PubMed ID: 27813662
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cartilage degradation and suppression of PGE
Akhtar N; Khan NM; Ashruf OS; Haqqi TM
Nutrition; 2017 Jan; 33():1-13. PubMed ID: 27908544
[TBL] [Abstract][Full Text] [Related]
14. Synovial fluid levels of TWEAK and matrix metalloproteinase 1 in patients with osteoarthritis, and associations with disease severity.
Hwang IY; Youm YS; Cho SD; Choi SW; Bae MH; Park SJ; Kim HW
J Orthop Surg (Hong Kong); 2018; 26(1):2309499018760112. PubMed ID: 29486670
[TBL] [Abstract][Full Text] [Related]
15. [Effect of various intervention factors on MMP-3 and TIMP-1 level in synovial fluid in knee joints with osteroarthritis].
Xu HT; Chen Y; Chen LK; Li JY; Zhang W; Wu B
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 33(1):47-52. PubMed ID: 18245904
[TBL] [Abstract][Full Text] [Related]
16. Intraarticular Matrix Metalloproteinases and Aggrecan Degradation Are Elevated After Articular Fracture.
Haller JM; Swearingen CA; Partridge D; McFadden M; Thirunavukkarasu K; Higgins TF
Clin Orthop Relat Res; 2015 Oct; 473(10):3280-8. PubMed ID: 26162411
[TBL] [Abstract][Full Text] [Related]
17. Increased level of cytokines and matrix metalloproteinases in osteoarthritic subchondral bone.
Hulejová H; Baresová V; Klézl Z; Polanská M; Adam M; Senolt L
Cytokine; 2007 Jun; 38(3):151-6. PubMed ID: 17689092
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
[TBL] [Abstract][Full Text] [Related]
19. [Influence of Bushen Huoxue decoction on beta-catenin, MMP-7 of synoviocytes in rats with knee osteoarthritis].
Yuan Q; Kan WB; Song PF; Zhao J; Yu WG; Wang YJ
Zhongguo Gu Shang; 2012 Sep; 25(9):761-5. PubMed ID: 23256367
[TBL] [Abstract][Full Text] [Related]
20. The infrapatellar fat pad produces interleukin-6-secreting T cells in response to a proteoglycan aggrecan peptide and provides dominant soluble mediators different from that present in synovial fluid.
Sae-Jung T; Leearamwat N; Chaiseema N; Sengprasert P; Ngarmukos S; Yuktananda P; Tanavalee A; Hirankarn N; Reantragoon R
Int J Rheum Dis; 2021 Jun; 24(6):834-846. PubMed ID: 34008313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
